Article Text

Download PDFPDF
CASE REPORT
Herpes simplex virus encephalitis in a patient receiving ustekinumab associated with extensive cerebral oedema and brainshift successfully treated by immunosuppression with dexamethasone

Footnotes

  • Twitter @BenedictNeuro

  • Contributors BDM conceived the idea of writing this case to be published. BDM, NS and VB were involved in the planning of the case report. HKVDT collected the clinical data and drafted the report. HKVDT, BDM, NS and VB all reviewed and made critical revisions to the drafted report. All authors gave final approval of the report prior to submission.

  • Funding BDM is supported by the NIHR HPRU for Emerging and Zoonotic Infection and the NIHR EME ISRCTN11774734.

  • Competing interests BDM reports grants from National Institute of Heath Research, grants from Welcome Trust, grants from Academy of Medical Sciences, grants from British Medical Association, grants from British Infection Association, outside the submitted work. NS reports personal fees from Novatis, personal fees from Eli Lilly, personal fees from Teva, personal fees from Allergan, personal fees from Electrocore, outside the submitted work.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Patient consent for publication Obtained.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Twitter @BenedictNeuro

  • Contributors BDM conceived the idea of writing this case to be published. BDM, NS and VB were involved in the planning of the case report. HKVDT collected the clinical data and drafted the report. HKVDT, BDM, NS and VB all reviewed and made critical revisions to the drafted report. All authors gave final approval of the report prior to submission.

  • Funding BDM is supported by the NIHR HPRU for Emerging and Zoonotic Infection and the NIHR EME ISRCTN11774734.

  • Competing interests BDM reports grants from National Institute of Heath Research, grants from Welcome Trust, grants from Academy of Medical Sciences, grants from British Medical Association, grants from British Infection Association, outside the submitted work. NS reports personal fees from Novatis, personal fees from Eli Lilly, personal fees from Teva, personal fees from Allergan, personal fees from Electrocore, outside the submitted work.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Patient consent for publication Obtained.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.